AccessGUDID - DEVICE: Rapid Response (10722066006624)

GUDID

Device Identifier (DI) Information

Brand Name: Rapid Response
Version or Model: D10.3.2-2FC1E
Commercial Distribution Status: In Commercial Distribution
Catalog Number:
Company Name: BTNX Inc

Primary DI Number: 10722066006624
Issuing Agency: GS1
Commercial Distribution End Date:
Device Count: 25
Labeler D-U-N-S® Number*: 251005005 *Terms of Use

Device Description: Rapid Response 10 Panel Saliva Test Cup E/I Screening (D10.3.2-2FC1E)- THC40, COC20, OPI40, AMP50, MET50, BAR50, BZO10, MDMA50, MTD30, PPX50. For employment and insurance testing.

Device Characteristics

What MRI safety information does the labeling contain?	Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437):	No
Device labeled as "Not made with natural rubber latex":	No
For Single-Use:	Yes
Prescription Use (Rx):	No
Over the Counter (OTC):	No
Kit:	Yes
Combination Product:	No
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P):	No

GMDN

[?]

GMDN Term Code	GMDN Term Name	GMDN Term Definition	GMDN Term Status [?]	Implantable?
46994	Multiple drugs of abuse IVD, kit, rapid ICT, clinical	A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.	Active	false

FDA Product Code

[?]

Product Code	Product Code Name
PVI	Test, Propoxyphene, Employment And Insurance Testing, Exempt
PUX	Test, Amphetamine, Employment And Insurance Testing, Exempt
PUY	Test, Barbiturate, Employment And Insurance Testing, Exempt
PUZ	Test, Benzodiazepine, Employment And Insurance Testing, Exempt
PVA	Test, Cocaine And Cocaine Metabolite, Employment And Insurance Testing, Exempt
PVB	Test, Codeine, Employment And Insurance Testing, Exempt
PVD	Test, Methamphetamine, Employment And Insurance Testing, Exempt
PVE	Test, Methadone, Employment And Insurance Testing, Exempt
PVF	Test, Methaqualone, Employment And Insurance Testing, Exempt
PVK	Test, Tricyclic Antidepressant Drugs, Employment And Insurance Testing, Exempt
PVJ	Test, Cannabinoid, Employment And Insurance Testing, Exempt
PVG	Test, Morphine, Employment And Insurance Testing, Exempt
PVH	Test, Opiates, Employment And Insurance Testing, Exempt

FDA Premarket Submission

FDA Premarket Submission Number [?]	Supplement Number [?]
Premarket Submission Number Not Available/Not Released

Device Exempt from Premarket Submission: No CLOSE

Sterilization

Device Packaged as Sterile: No
Requires Sterilization Prior to Use: No

Sterilization Method [?]
No Sterilization Methods Found

Storage and Handling

[?]

Storage and Handling
No storage/handling found

Clinically Relevant Size

[?]

Size Type Text
No Device Sizes

Device Record Status

Public Device Record Key: db5042e6-7906-40aa-88b6-69d8b485c1d5
Public Version Date: April 20, 2023
Public Version Number: 2
DI Record Publish Date: December 07, 2022